Works by van den Berkmortel, F. W. P. J.

Results: 7

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1124, doi. 10.1038/s41416-025-03021-5

By:

Bloem, M.;
de Meza, M. M.;
van den Eertwegh, A. J. M.;
Aarts, M. J. B.;
van den Berkmortel, F. W. P. J.;
Blank, C. U.;
Blokx, W. A. M.;
Boers-Sonderen, M. J.;
Bonenkamp, J. J.;
Boreel, C. D. M.;
de Groot, J. W. B.;
Haanen, J. B. A. G.;
Hospers, G. A. P.;
Kapiteijn, E.;
van Not, O. J.;
Piersma, D.;
Rikhof, B.;
Stevense-den Boer, A. M.;
van der Veldt, A. A. M.;
Vreugdenhil, G.

Publication type:

Article

Effect of rIFN-γ on Antibody-Mediated Cytotoxicity via Human Monocyte IgG Fc Receptor II (CD32).

Published in:

Scandinavian Journal of Immunology, 1992, v. 36, n. 3, p. 385, doi. 10.1111/j.1365-3083.1992.tb02952.x

By:

van Schie, R. C. A. A.;
Verstraten, H. G. G.;
Tax, W. J. M.;
van den Berkmortel, F. W. P. J.;
van de Winkel, J. G. J.;
de Mulder, P. H. M.

Publication type:

Article

Progressive arterial wall stiffening in patients with increasing diastolic blood pressure.

Published in:

Journal of Human Hypertension, 2001, v. 15, n. 10, p. 685, doi. 10.1038/sj.jhh.1001245

By:

van den Berkmortel, F W P J;
van der Steen, M;
Hoogenboom, H;
Wollersheim, H;
van Langen, H;
Thien, Th

Publication type:

Article

Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation.

Published in:

European Journal of Clinical Investigation, 2000, v. 30, n. 11, p. 972, doi. 10.1046/j.1365-2362.2000.00739.x

By:

van den Berkmortel, F. W. P. J.;
Demacker, P. N. M.;
Wollersheim, H.;
Thien, T.;
Stalenhoef, A. F. H.

Publication type:

Article

Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12336-0

By:

Janssen, J. C.;
van Dijk, B.;
de Joode, K.;
Aarts, M. J. B.;
van den Berkmortel, F. W. P. J.;
Blank, C. U.;
Boers-Sonderen, M. J.;
van den Eertwegh, A. J. M.;
de Groot, J. W. B.;
Jalving, M.;
de Jonge, M. J. A.;
Joosse, A.;
Kapiteijn, E.;
Kamphuis-Huismans, A. M.;
Naipal, K. A. T.;
Piersma, D.;
Rikhof, B.;
Westgeest, H. M.;
Vreugdenhil, G.;
Oomen-de Hoop, E.

Publication type:

Article

Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort.

Published in:

Pigment Cell & Melanoma Research, 2024, v. 37, n. 1, p. 15, doi. 10.1111/pcmr.13117

By:

Borgers, J. S. W.;
Burgers, F. H.;
Schina, A.;
Van Not, O. J.;
van den Eertwegh, A. J. M.;
Blank, C. U.;
Aarts, M. J. B.;
van den Berkmortel, F. W. P. J.;
de Groot, J. W. B.;
Hospers, G. A. P.;
Kapiteijn, E.;
Piersma, D.;
van Rijn, R. S.;
Boer, A. M. Stevense‐den;
van der Veldt, A. A. M.;
Vreugdenhil, G.;
Boers‐Sonderen, M. J.;
Wouters, M. W. J. M.;
Suijkerbuijk, K. P. M.;
van Thienen, J. V.

Publication type:

Article

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.

Published in:

2021

By:

Mulder, E. E. A. P.;
de Joode, K.;
Litière, S.;
ten Tije, A. J.;
Suijkerbuijk, K. P. M.;
Boers-Sonderen, M. J.;
Hospers, G. A. P.;
de Groot, J. W. B.;
van den Eertwegh, A. J. M.;
Aarts, M. J. B.;
Piersma, D.;
van Rijn, R. S.;
Kapiteijn, E.;
Vreugdenhil, G.;
van den Berkmortel, F. W. P. J.;
Hoop, E. Oomen-de;
Franken, M. G.;
Ryll, B.;
Rutkowski, P.;
Sleijfer, S.

Publication type:

journal article